Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,248 | 0 | N/A | 0 | 0 |
| Marketable Securities | 12,308 | 0 | N/A | 0 | 0 |
| Receivables | 1,461 | 0 | N/A | 0 | 0 |
| TOTAL | $49,749 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 7,315 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 18,848 | 0 | 0 | 0 | 0 |
| TOTAL | $26,163 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $75,912 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 823 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 6,214 | 0 | N/A | 0 | 0 |
| TOTAL | $10,827 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 256,076 | 0 | 0 | 0 | 0 |
| TOTAL | $256,182 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $267,009 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,287 | N/A | N/A | N/A | N/A |
| Retained earnings | -213,117 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | 121 | 0 | 0 | 0 | 0 |
| TOTAL | $-191,097 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $75,912 | $0 | $0 | $0 | $0 |